Cargando…

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment

In vivo modeling combined with CRISPR/Cas9-mediated somatic genome editing has contributed to elucidating the functional importance of specific genetic alterations in human tumors. Our recent work uncovered tumor suppressor pathways that affect EGFR-driven lung tumor growth and sensitivity to tyrosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foggetti, Giorgia, Li, Chuan, Cai, Hongchen, Petrov, Dmitri A., Winslow, Monte M., Politi, Katerina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Author’s Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890383/ https://www.ncbi.nlm.nih.gov/pubmed/35252550 http://dx.doi.org/10.1080/23723556.2021.1994328

Ejemplares similares

Conditional haploinsufficiency of the retinoblastoma tumor suppressor gene
por: Ishak, Charles A, et al.
Publicado: (2014)

Tumor suppressor ARF: The new player of innate immunity
por: Través, Paqui G., et al.
Publicado: (2012)

Sestrin1, a tumor suppressor that can be rescued
por: Donaldson, Maria C., et al.
Publicado: (2017)

Restoration of tumor suppressor functions by small-molecule inhibitors
por: Pyndiah, Slovénie, et al.
Publicado: (2015)

TDG is a novel tumor suppressor of liver malignancies
por: Hassan, Haider M., et al.
Publicado: (2020)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

Disentangling PTEN-cooperating tumor suppressor gene networks in cancer
por: de la Rosa, Jorge, et al.
Publicado: (2017)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

B7x and myeloid-derived suppressor cells in the tumor microenvironment: A tale of two cities
por: Jeon, Hyungjun, et al.
Publicado: (2013)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

Hypoxia and tumor-associated macrophages: A deadly alliance in support of tumor progression
por: Van Overmeire, Eva, et al.
Publicado: (2014)

Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
por: Heinemann, Anja, et al.
Publicado: (2012)

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015)

Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth
por: Hervieu, Alexia, et al.
Publicado: (2020)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

The hedgehog’s trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors
por: Xie, Jingwu
Publicado: (2014)

Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
por: Martens, Alexander, et al.
Publicado: (2014)

Notch and TGFβ: Functional partners facilitating tumor progression
por: Ohnuki, Hidetaka, et al.
Publicado: (2014)

Role of c-MYC in tumor-associated macrophages and cancer progression
por: Pello, Oscar M., et al.
Publicado: (2013)

Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression
por: Deng, Liufu, et al.
Publicado: (2014)

Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression
por: Abrams, Scott I., et al.
Publicado: (2012)

The microenvironment reprograms circuits in tumor cells
por: Cai, Qingchun, et al.
Publicado: (2015)

EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies
por: Derer, Stefanie, et al.
Publicado: (2013)

An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition
por: Palena, Claudia, et al.
Publicado: (2014)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression
por: Demers, Mélanie, et al.
Publicado: (2013)

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols
por: Raccosta, Laura, et al.
Publicado: (2013)

Tumor-infiltrating B cells: The ignored players in tumor immunology
por: Linnebacher, Michael, et al.
Publicado: (2012)

Oncogenic context shapes the fitness landscape of tumor suppression
por: Blair, Lily M., et al.
Publicado: (2023)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012)

Tumor-targeting vaccination instructs graft-vs.-tumor immune responses
por: Manzo, Teresa, et al.
Publicado: (2013)

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression
por: Escobar, Giulia, et al.
Publicado: (2014)

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
por: Li, Hai, et al.
Publicado: (2012)

Within tumors, interactions between T cells and tumor cells are impeded by the extracellular matrix
por: Salmon, Hélène, et al.
Publicado: (2012)

mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression
por: Drusian, Luca, et al.
Publicado: (2018)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g33ff1e6o6kjasiq923b0trtao